Session 8: Advanced Ovarian Cancer Therapies: PARP Inhibitors and Beyond
8:15 AM – 8:50 AM ET
Session 8: Advanced Ovarian Cancer Therapies: PARP Inhibitors and Beyond
Debra Richardson, MD (she/her/hers) – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186893###Invited Speaker###Associate Professor###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###
Invited Speaker: Debra Richardson, MD (she/her/hers) – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### she/her/hers
8:50 AM – 9:00 AM ET
Live Q&A
8:50 AM – 9:00 AM ET
Live Q&A
Moderator: Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###
Moderator: Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Debra Richardson, MD (she/her/hers) – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186893###Invited Speaker###Associate Professor###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###
Invited Speaker: Debra Richardson, MD (she/her/hers) – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### she/her/hers
9:00 AM – 9:15 AM ET
Break
9:00 AM – 9:15 AM ET
Break
9:15 AM – 9:50 AM ET
Session 9: Relapsing Ovarian Cancer: Expert Advice for Selecting New and Emerging Targeted Therapeutics
9:15 AM – 9:50 AM ET
Session 9: Relapsing Ovarian Cancer: Expert Advice for Selecting New and Emerging Targeted Therapeutics
Presenter: Colleen McCormick, MD, MPH – University of New Mexico Cancer Center
Colleen McCormick, MD, MPH (she/her/hers) – University of New Mexico Cancer Center ### 1953572###Presenter###Associate Professor, Gynecologic Oncology###University of New Mexico Cancer Center###
Presenter: Colleen McCormick, MD, MPH (she/her/hers) – University of New Mexico Cancer Center
### she/her/hers
9:50 AM – 10:00 AM ET
Live Q&A
9:50 AM – 10:00 AM ET
Live Q&A
Moderator: Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter: Colleen McCormick, MD, MPH – University of New Mexico Cancer Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###
Moderator: Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Colleen McCormick, MD, MPH (she/her/hers) – University of New Mexico Cancer Center ### 1953572###Presenter###Associate Professor, Gynecologic Oncology###University of New Mexico Cancer Center###
Presenter: Colleen McCormick, MD, MPH (she/her/hers) – University of New Mexico Cancer Center
### she/her/hers
10:00 AM – 10:15 AM ET
Break
10:00 AM – 10:15 AM ET
Break
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
11:15 AM – 11:30 AM ET
Break
11:15 AM – 11:30 AM ET
Break
11:30 AM – 12:05 PM ET
Session 10: Food Insecurity in Oncology
11:30 AM – 12:05 PM ET
Session 10: Food Insecurity in Oncology
Presenter: Christina Washington, MD – University of Oklahoma
Christina Washington, MD (she/her/hers) – University of Oklahoma ### 1862808###Presenter###Assistant Professor### University of Oklahoma###
Presenter: Christina Washington, MD (she/her/hers) – University of Oklahoma
### she/her/hers
12:05 PM – 12:15 PM ET
Live Q&A
12:05 PM – 12:15 PM ET
Live Q&A
Moderator: Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter: Christina Washington, MD – University of Oklahoma
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###
Moderator: Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Christina Washington, MD (she/her/hers) – University of Oklahoma ### 1862808###Presenter###Assistant Professor### University of Oklahoma###
Presenter: Christina Washington, MD (she/her/hers) – University of Oklahoma
### she/her/hers
12:15 PM – 12:30 PM ET
Break
12:15 PM – 12:30 PM ET
Break
12:30 PM – 1:05 PM ET
Session 11: Updates from Recent Meetings
12:30 PM – 1:05 PM ET
Session 11: Updates from Recent Meetings
Presenter: Ramez Eskander, MD – University of California, San Diego
Ramez Eskander, MD – University of California, San Diego ### 1416358###Presenter###Associate Professor###University of California, San Diego###
Presenter: Ramez Eskander, MD – University of California, San Diego
###
1:05 PM – 1:15 PM ET
Live Q&A
1:05 PM – 1:15 PM ET
Live Q&A
Presenter: Ramez Eskander, MD – University of California, San Diego
Ramez Eskander, MD – University of California, San Diego ### 1416358###Presenter###Associate Professor###University of California, San Diego###
Presenter: Ramez Eskander, MD – University of California, San Diego
###
1:15 PM – 1:30 PM ET
Break
1:15 PM – 1:30 PM ET
Break
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
2:30 PM – 2:45 PM ET
Break
2:30 PM – 2:45 PM ET
Break
2:45 PM – 3:20 PM ET
Session 12: Collateral Damage: Side Effects of Breast Cancer Treatment
2:45 PM – 3:20 PM ET
Session 12: Collateral Damage: Side Effects of Breast Cancer Treatment
Presenter: Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center
Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center ### 1897031###Presenter###Nurse Practitioner###Texas Oncology -Baylor Charles A. Sammons Cancer Center###
Presenter: Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center
###
3:20 PM – 3:30 PM ET
Live Q&A
3:20 PM – 3:30 PM ET
Live Q&A
Moderator: Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI)
Presenter: Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center
Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI) ### 1186741###Moderator###Director, Breast and Gynecologic Cancer Research Program###Sarah Cannon Research Institute (SCRI)###
Moderator: Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI)
### @@@ Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center ### 1897031###Presenter###Nurse Practitioner###Texas Oncology -Baylor Charles A. Sammons Cancer Center###
Presenter: Marissa Marti-Smith, MSN, APRN, AGNP-C, AOCNP – Texas Oncology -Baylor Charles A. Sammons Cancer Center
###
3:30 PM – 3:45 PM ET
Break
3:30 PM – 3:45 PM ET
Break
3:45 PM – 4:30 PM ET
Session 13: Debate: Should We Quantify HER-2 Expression for Use of TDXd and Other ADCs?
3:45 PM – 4:00 PM ET
Session 13: Debate: Should We Quantify HER-2 Expression for Use of TDXd and Other ADCs? - YES
Presenter: Giuseppe Curigliano, Professor MD PhD – European Insitute of Oncology, IRCCS and University of Milano
Giuseppe Curigliano, Professor MD PhD (he/him/his) – European Insitute of Oncology, IRCCS and University of Milano ### 1867030###Presenter###Clinical Director Early Drug Development Division###European Insitute of Oncology, IRCCS and University of Milano###
Presenter: Giuseppe Curigliano, Professor MD PhD (he/him/his) – European Insitute of Oncology, IRCCS and University of Milano
### he/him/his
4:00 PM – 4:15 PM ET
Session 13: Debate: Should We Quantify HER-2 Expression for Use of TDXd and Other ADCs? - NO
Presenter: Paolo Tarantino, MD – Dana-Farber Cancer Institute, Harvard Medical School
Paolo Tarantino, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 1928334###Presenter###Advanced Research Fellow###Dana-Farber Cancer Institute, Harvard Medical School###
Presenter: Paolo Tarantino, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his
4:15 PM – 4:30 PM ET
Live Panel Discussion
Moderator: Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI)
Panelist: Giuseppe Curigliano, Professor MD PhD – European Insitute of Oncology, IRCCS and University of Milano
Panelist: Paolo Tarantino, MD – Dana-Farber Cancer Institute, Harvard Medical School
Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI) ### 1186741###Moderator###Director, Breast and Gynecologic Cancer Research Program###Sarah Cannon Research Institute (SCRI)###
Moderator: Erika P. Hamilton, MD – Sarah Cannon Research Institute (SCRI)
### @@@ Giuseppe Curigliano, Professor MD PhD (he/him/his) – European Insitute of Oncology, IRCCS and University of Milano ### 1867030###Panelist###Clinical Director Early Drug Development Division###European Insitute of Oncology, IRCCS and University of Milano###
Panelist: Giuseppe Curigliano, Professor MD PhD (he/him/his) – European Insitute of Oncology, IRCCS and University of Milano
### he/him/his @@@ Paolo Tarantino, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School ### 1928334###Panelist###Advanced Research Fellow###Dana-Farber Cancer Institute, Harvard Medical School###
Panelist: Paolo Tarantino, MD (he/him/his) – Dana-Farber Cancer Institute, Harvard Medical School
### he/him/his
4:30 PM – 4:45 PM ET
Break
4:30 PM – 4:45 PM ET
Break
4:45 PM – 5:20 PM ET
Session 14: CDK4/6 Inhibitors Results in Early and Metastatic Breast Cancer
4:45 PM – 5:20 PM ET
Session 14: CDK4/6 Inhibitors Results in Early and Metastatic Breast Cancer
Presenter: Komal Jhaveri, MD, FACP – Memorial Sloan Kettering Cancer Center
Komal Jhaveri, MD, FACP – Memorial Sloan Kettering Cancer Center ### 1416347###Presenter###Medical Oncologist and Clinical Researcher, Breast Medicine and Early Drug Development###Memorial Sloan Kettering Cancer Center###
Presenter: Komal Jhaveri, MD, FACP – Memorial Sloan Kettering Cancer Center
###
5:20 PM – 5:30 PM ET
Live Q&A
5:20 PM – 5:30 PM ET
Live Q&A
Presenter: Komal Jhaveri, MD, FACP – Memorial Sloan Kettering Cancer Center
Komal Jhaveri, MD, FACP – Memorial Sloan Kettering Cancer Center ### 1416347###Presenter###Medical Oncologist and Clinical Researcher, Breast Medicine and Early Drug Development###Memorial Sloan Kettering Cancer Center###
Presenter: Komal Jhaveri, MD, FACP – Memorial Sloan Kettering Cancer Center
